Drug Database
Back to search

France· FR:65968176

GINKOPLANT 40 mg, comprimé pelliculé

A medicinal product containing ginkgo (feuille de) (extrait sec de), registered in France by WILLMAR SCHWABE.

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedGINKOPLANT 40 mg, comprimé pelliculéATC—REGISTER NO.FR:65968176PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ginkgo (feuille de) (extrait sec de)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
GINKGO (FEUILLE DE) (EXTRAIT SEC DE)
Manufacturer
WILLMAR SCHWABE
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400930021200
    plaquette(s) thermoformée(s) PVC aluminium PVDC de 30 comprimé(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ginkgo (feuille de) (extrait sec de) in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ginkgo (feuille de) (extrait sec de) products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Germany · Synapsan
  • Denmark · Bio-Biloba
  • Estonia · Bio-Biloba
  • Spain · Incebral
  • Croatia · Bilobil Intense
  • Hungary · Tebofortan
  • Poland · Ginkgofol
  • Portugal · Abolibe Forte, Biloban
  • Slovakia · Gingio

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4b15ad62-1faa-403e-b911-6785be467c96
GET /v1/drugs/4b15ad62-1faa-403e-b911-6785be467c96?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65968176",
  "date_amm": "2017-08-11",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "GINKGO (FEUILLE DE) (EXTRAIT SEC DE)",
  "statut_amm": "Autorisation active",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about ginkgo (feuille de) (extrait sec de).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console